SpineGuard Strengthens Its DSG Technology With the Validation of French and European Patents About Bone Quality Measurement finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Just one mRNA vaccine dose sufficient for people with prior SARS-CoV-2 infection news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
The U.S. government s recommended pause on the Johnson & Johnson COVID-19 vaccine due to a rare side effect will remain at least another week, after a Centers for Disease Control and Prevention panel decided Wednesday it needed time to evaluate more data.
With more than 3.7 million J&J shots administered in the two and a half weeks before the April 13 halt, additional information on the rare blood clotting condition is expected. But some health experts fear prolonging the pause may do more harm than good.
“When you have a long pause that’s not rapidly resolved, it stirs worry and fear on the part of people who are already vaccine hesitant,” said Dr. Arthur Caplan, a professor of bioethics at the NYU School of Medicine in New York City.
One vaccine dose may be enough for people who had COVID-19, Penn research shows phillyvoice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phillyvoice.com Daily Mail and Mail on Sunday newspapers.
Targeted News Service targetednews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from targetednews.com Daily Mail and Mail on Sunday newspapers.